Michael P. Dube's Insider Trades & SAST Disclosures
Michael P. Dube's most recent trade in Intellia Therapeutics Inc was a trade of 14,000 Common Stock done . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael P. Dube.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | Michael P. Dube | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 14,000 | 59,640 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Michael P. Dube | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 12.18 per share. | 03 Jan 2025 | 1,372 | 45,640 (0%) | 0% | 12.2 | 16,711 | Common Stock |
| Intellia Therapeutics Inc | Michael P. Dube | VP, Chief Accounting Officer | 02 Oct 2024 | 2,012 | 47,012 (0%) | 0% | 19.0 | 38,248 | Common Stock | |
| Intellia Therapeutics Inc | Michael P. Dube | VP, PAO and Interim PFO | 01 Jul 2024 | 17,801 | 49,024 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges